Idiopathic Thrombocytopenic Purpura (ITP) News

This RSS feed URL is deprecated


This RSS feed URL is deprecated, please update. New URLs can be found in the footers at https://news.google.com/news

Nurse award recipient announced - Journal Gazette and Times-Courier



Journal Gazette and Times-Courier
 
Nurse award recipient announced 
Journal Gazette and Times-Courier
During the award presentation, McDevitt received a certificate, a DAISY Award pin and a unique, hand-carved serpentine stone sculpture from Zimbabwe, entitled, ?A Healer's Touch.? The DAISY Award was established in memory of J. Patrick Barnes, who died ...

 


Clinical Practice Updates in the Management Of Immune Thrombocytopenia - P&T Community



Clinical Practice Updates in the Management Of Immune Thrombocytopenia 
P&T Community
Immune thrombocytopenia (ITP), previously called idiopathic thrombocytopenia purpura, is an autoimmune disorder characterized by a severe reduction in peripheral blood platelet count. In healthy individuals, normal platelet count ranges from 150?450 ...

 


Santa visits Red Deer to give the gift of life | rdnewsNOW - rdnewsnow.com



rdnewsnow.com
 
Santa visits Red Deer to give the gift of life | rdnewsNOW 
rdnewsnow.com
Santa Claus made a stop in Red Deer on Friday to deliver an early Christmas present. He visited Canadian Blood Services to give the gift of life by donating blood and encourage others to do the same this holiday season.

and more » 


Dova Pharmaceuticals Announces Four Presentations at the 59th American Society of Hematology Annual Meeting - GlobeNewswire (press release)



Dova Pharmaceuticals Announces Four Presentations at the 59th American Society of Hematology Annual Meeting 
GlobeNewswire (press release)
DURHAM, N.C., Dec. 04, 2017 (GLOBE NEWSWIRE) -- Dova Pharmaceuticals, Inc. (NASDAQ:DOVA) today announced that the Company will present four abstracts, three of which will be oral presentations, with data from Phase 3 clinical trials of avatrombopag in ...

and more » 


Global Intravenous Immunoglobulin Market Analysis & Trends - Industry Forecast to 2025 - Markets Insider



Global Intravenous Immunoglobulin Market Analysis & Trends - Industry Forecast to 2025 
Markets Insider
By application the market is classified into primary humoral immunodeficiency, immunodeficiency diseases, myasthenia gravis, hypogammaglobulinemia, chronic inflammatory demyelinating polyneuropathy (CIDP), inflammatory myopathies, kawasaki disease ...

 


Amgen Gets Positive CHMP Opinion to Expand Nplate's Label - Nasdaq



Amgen Gets Positive CHMP Opinion to Expand Nplate's Label 
Nasdaq
Amgen, Inc. AMGN announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has given a positive opinion to expand the label of Nplate to include the pediatric population. Nplate is presently ...

and more » 


Castle Douglas woman Laura Thomson raises more than £1000 for charity despite dislocated shoulder - Scottish Daily Record



Scottish Daily Record
 
Castle Douglas woman Laura Thomson raises more than £1000 for charity despite dislocated shoulder 
Scottish Daily Record
A Castle Douglas woman ran through the pain of a dislocated shoulder to raise money for a cause close to her heart. Twenty-six-year-old Laura Thomson took on the Great Scottish Run in Glasgow last month to raise money for Immune Thrombocytopenic ...

 


Positive Interim Data Reported From Intravenous Immunoglobulin Phase 3 Trial - Pharmaceutical Processing



The Korea Herald
 
Positive Interim Data Reported From Intravenous Immunoglobulin Phase 3 Trial 
Pharmaceutical Processing
... one of the lowest IVIG self-sufficiency ratios (i.e. less than 20 percent). Intravenous immunoglobulin is a preparation of antibodies purified from plasma donations from healthy individuals. It is indicated for the maintenance treatment of patients ...
Prometic Reports Positive Interim Clinical Data from Ongoing Intravenous Immunoglobulin (IVIG) Pivotal Phase 3 Trial PharmiWeb.com (press release)

all 5 news articles » 


Positive opinion to extend use of romiplostim in paediatric patients - Hospital Healthcare Europe



Positive opinion to extend use of romiplostim in paediatric patients 
Hospital Healthcare Europe
Amgen has announced that the Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion to expand the current indication for Nplate® (romiplostim) to include the treatment of chronic ...

 


Amgen's Nplate recommended for EU approval in paediatric indication - Zenopa



Amgen's Nplate recommended for EU approval in paediatric indication 
Zenopa
Amgen has announced that its thrombocytopenic purpura therapy Nplate has been recommended for EU approval in a new paediatric indication. The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency has backed the ...